Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 22nd March 2023

    FIRST PATIENT DOSED IN SECOND PHASE I CLINICAL TRIAL OF AT278

  • 16th February 2023

    ARECOR GRANTED PATENTS IN INDIA AND THE UNITED STATES PROTECTING PROPRIETARY FORMULATIONS

  • 14th February 2023

    ARECOR STRENGTHENS COLLABORATION WITH TOP 5 GLOBAL PHARMACEUTICAL PARTNER THROUGH ADDITIONAL FORMULATION AGREEMENT